• LAST PRICE
    14.8100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    14.2000/ 1
  • Ask / Lots
    15.9000/ 1
  • Open / Previous Close
    14.3000 / 14.8100
  • Day Range
    Low 14.2000
    High 15.0600
  • 52 Week Range
    Low 2.3600
    High 16.2800
  • Volume
    136,742
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 14.27
TimeVolumeATXS
09:32 ET70814.3
09:35 ET70014.31
09:37 ET30014.2
09:39 ET78014.3
09:42 ET60014.205
09:44 ET20014.25
09:46 ET247014.25
09:48 ET33714.25
09:50 ET450014.3
09:51 ET40014.35
09:53 ET900014.35
09:55 ET10014.395
10:00 ET75014.7695
10:02 ET24014.8799
10:04 ET10014.7532
10:06 ET525414.725
10:09 ET32014.8
10:13 ET40014.8999
10:15 ET70014.94
10:18 ET10014.96
10:20 ET290015
10:24 ET40014.93
10:26 ET50014.9769
10:27 ET10014.9
10:29 ET20014.87
10:36 ET30014.885
10:38 ET132114.835
10:49 ET84514.725
10:51 ET20014.765
10:54 ET21114.736
10:56 ET12514.74
10:58 ET33014.8
11:07 ET20014.95
11:12 ET10014.89
11:20 ET88214.81
11:21 ET278214.77
11:23 ET1045214.8
11:27 ET20014.88
11:30 ET10014.91
11:32 ET10014.94
11:34 ET390414.95
11:41 ET20014.93
11:43 ET59814.9
11:45 ET20014.88
11:50 ET10014.835
11:52 ET10014.87
11:54 ET110014.83
11:56 ET40014.8454
12:01 ET110014.81
12:08 ET10014.785
12:14 ET50014.79
12:17 ET70914.86
12:21 ET61814.83
12:26 ET10014.8
12:28 ET20014.78
12:30 ET20014.74
12:32 ET60214.81
12:35 ET20014.805
12:42 ET30014.79
12:44 ET20014.77
12:46 ET64914.7
12:50 ET53514.67
12:53 ET40014.64
12:55 ET61814.65
01:00 ET30014.715
01:02 ET32814.69
01:06 ET60914.725
01:08 ET40014.705
01:11 ET30014.65
01:13 ET104014.7
01:18 ET10014.76
01:20 ET20014.76
01:24 ET40014.7
01:27 ET30014.75
01:31 ET60014.75
01:33 ET10014.77
01:36 ET20014.8
01:40 ET40014.76
01:42 ET30014.74
01:44 ET10014.73
01:45 ET20014.75
01:47 ET70014.77
01:51 ET40114.81
01:54 ET10014.832
01:56 ET38614.81
01:58 ET57214.84
02:05 ET80014.805
02:07 ET88414.8
02:09 ET15014.8307
02:16 ET30014.79
02:18 ET20114.84
02:21 ET10014.87
02:23 ET20014.81
02:25 ET90014.8
02:27 ET114914.74
02:30 ET20014.755
02:32 ET40014.77
02:34 ET10014.78
02:38 ET10014.75
02:41 ET80014.635
02:43 ET20014.63
02:45 ET20014.59
02:48 ET97414.63
02:50 ET60014.7
02:52 ET20014.64
02:54 ET70014.71
02:57 ET20014.73
02:59 ET60114.73
03:03 ET60014.76
03:06 ET30014.68
03:08 ET20014.72
03:10 ET80014.69
03:12 ET30014.69
03:14 ET10014.72
03:15 ET10014.67
03:19 ET20014.67
03:21 ET41814.705
03:26 ET60114.73
03:28 ET10014.75
03:30 ET30014.735
03:32 ET10014.75
03:33 ET156514.755
03:35 ET20014.77
03:37 ET10014.76
03:39 ET10514.74
03:42 ET55714.74
03:44 ET10014.74
03:46 ET40014.71
03:48 ET22014.74
03:50 ET30014.73
03:51 ET40014.74
03:53 ET43514.72
03:55 ET142414.71
03:57 ET56014.73
04:00 ET406614.81
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesATXS
Astria Therapeutics Inc
392.4M
-4.1x
---
United StatesIRON
Disc Medicine Inc
393.1M
-2.4x
---
United StatesGLUE
Monte Rosa Therapeutics Inc
397.4M
-3.5x
---
United StatesRGC
Regencell Bioscience Holdings Ltd
385.2M
-50.5x
---
United StatesPMVP
PMV Pharmaceuticals Inc
376.3M
-5.1x
---
United StatesVIGL
Vigil Neuroscience Inc
375.4M
-5.2x
---
As of 2023-02-07

Company Information

Astria Therapeutics, Inc. is a biopharmaceutical company focused on discovering, developing and commercialization of therapies to patients and families affected by rare and niche allergic and immunological diseases. The Company’s lead product candidate is STAR-0215, is a potential monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema (HAE). HAE is a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen and airway. STAR-0215 is a monoclonal antibody inhibitor of plasma kallikrein, which is designed to provide long-acting attack prevention for HAE. The Company’s on-demand treatment of HAE therapy includes BERINERT, FIRAZYR, KALBITOR and RUCONEST. Its long-term preventative treatment of HAE therapy includes CINRYZE, HAEGARDA, TAKHZYRO and ORLADEYO.

Contact Information

Headquarters
75 State Street, Suite 1400BOSTON, MA, United States 02109
Phone
617-349-1971
Fax
617-273-2637

Executives

Independent Chairman of the Board
Kenneth Bate
President, Chief Executive Officer, Co-Founder, Principal Financial Officer, Director
Jill Milne
Chief Financial Officer
Noah Clauser
Chief Scientific Officer
Andrew Nichols
Chief Legal Officer
Benjamin Harshbarger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$392.4M
Revenue (TTM)
$0.00
Shares Outstanding
27.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.88
EPS
$-3.64
Book Value
$9.40
P/E Ratio
-4.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.